Icon Clinical Research (U.K.) No. 6 Limited

Active09743789 Private limited company
Incorporated
21 August 2015 (11 years)
Previously known as
Medpass Group Limited (until 19 April 2021)
Industry
Activities of other holding companies n.e.c. (64209)
Directors
Simon Hollywood
Emer Lyons
Owned by
Icon PLC
Accounts type
Full
Region
South East
Address
3rd Floor
North & South Wings 100 Longwater Avenue
Green Park
Reading
RG2 6GP

Filing status

Accounts due
31 December 2026
Last accounts
31 December 2024
Conf. stmt due
29 March 2027
Last conf. stmt
15 March 2026

Officers 3 active

Officer details are public data from the Companies House register.

Hollywood, Simon
Director · Appointed 12 October 2023
Irish
Born January 1980 (46)
Lyons, Emer
Director · Appointed 12 October 2023
Irish
Born January 1978 (48)
Fox, Erina
Secretary · Appointed 22 January 2020
Officer history (6 former)
12 October 2023
Resigned O'Boyle, Bryan as Director
12 October 2023
Appointed Lyons, Emer as Director
12 October 2023
Appointed Hollywood, Simon as Director
12 October 2023
Resigned Harte, Brendan as Director
21 October 2022
Resigned Gleeson, Michael as Director
8 April 2021
Resigned Sorrel, Sarah Anne as Director
8 April 2021
Resigned Grove, Harvey Gordon Edwin as Director
22 January 2020
Appointed Gleeson, Michael as Director
22 January 2020
Appointed O'Boyle, Bryan as Director
22 January 2020
Appointed Harte, Brendan as Director
22 January 2020
Resigned Grove, Harvey Gordon Edwin as Secretary
22 January 2020
Appointed Fox, Erina as Secretary
17 April 2019
Appointed Grove, Harvey Gordon Edwin as Director
21 August 2015
Appointed Grove, Harvey Gordon Edwin as Secretary
21 August 2015
Appointed Sorrel, Sarah Anne as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Icon PLC
Corporate entity · Notified 22 January 2020
Owns 75–100% of shares
Holds 75–100% of voting rights
Plc

Holdings 1

Companies where Icon Clinical Research (U.K.) No. 6 Limited is registered as a person with significant control

Active
Former controllers (1)
22 January 2020
Ceased Sarah Anne Sorrel — Owns 50–75% of shares

Financials

Balance sheet as at 31 December 2024 · full accounts

Cash
£141,441
Profit Before Tax
(£3,643)
Employees
2

Trend

Profit Before Tax
(£20.0M) £0 £20.0M £40.0M 2021 2022 2023 2024 £22,966,877 £1,372,139 £5,529,508 (£3,643)
Balance sheet detail
20242023202220212019
Fixed Assets£778
Current Assets£32,153,167£32,174,879£26,647,718£25,510,867£2,431,489
Debtors£32,011,726£32,008,781£26,631,580£25,503,782
Cash£141,441£166,098£16,138£7,085
Creditors (< 1 year)£7,200
Net Current Assets£32,143,028£32,144,279£26,641,578£25,503,667£2,431,489
Net Assets£25,504,447£2,430,934
Shareholder Funds£25,504,447£2,430,934

Filings 49

DateDescriptionMade Up ToPagesPDF
2 April 2026Confirmation statement with no updates15 March 2026
6 January 2026Full accounts31 December 2024
30 May 2025Registered office address changed
20 March 2025Confirmation statement with no updates15 March 2025
16 January 2025Full accounts31 December 2023
Show all 49 filings

Some other companies at this address

Other companies in this industry

By trade and location

New companies in Reading →

Explore the largest companies

Largest companies in Reading, UK →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?